Interest of PET-PSMA Imaging Potentialised by Androgen Blockade in Localized Prostatic Adenocarcinoma
Status:
Recruiting
Trial end date:
2022-02-04
Target enrollment:
Participant gender:
Summary
Evaluation of the interest of PET-PSMA imaging potentiated by androgen blockade in patients
with biological relapse or persistent biological disease of a localized prostatic
adenocarcinoma after initial treatment